Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma

por Zhu, Shanli, Chen, Jun, Xiong, Yirong, Kamara, Saidu, Gu, Meiping, Tang, Wanlin, Chen, Shao, Dong, Haiyan, Xue, Xiangyang, Zheng, Zhi-Ming, Zhang, Lifang
Publicado 2020

Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells

por Zhu, Jinshun, Kamara, Saidu, Cen, Danwei, Tang, Wanlin, Gu, Meiping, Ci, Xingyuan, Chen, Jun, Wang, Lude, Zhu, Shanli, Jiang, Pengfei, Chen, Shao, Xue, Xiangyang, Zhang, Lifang
Publicado 2020

Correction: Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells

por Zhu, Jinshun, Kamara, Saidu, Cen, Danwei, Tang, Wanlin, Gu, Meiping, Ci, Xingyuan, Chen, Jun, Wang, Lude, Zhu, Shanli, Jiang, Pengfei, Chen, Shao, Xue, Xiangyang, Zhang, Lifang
Publicado 2020